Megalabs, a leading pharmaceutical company, has acquired a majority stake in DS Labs, a key player in the dermatology market specializing in science-backed haircare and skincare solutions. WHO: Founded in 2007, DS Laboratories is a pioneering dermatology company known for its advanced haircare products, operating in over 50+ countries. It markets through online channels, specialty retailers, distributors, and pharmacies. Its research has led to a highly innovative portfolio of hair growth and hair loss products.Megalabs is a pharmaceutical company committed to providing healthcare professionals and consumers with affordable therapeutic solutions for a healthier and more fulfilling life. Megalabs has a presence in 20 countries with more than 8,000 collaborators supported by 18 production plants, a highly diversified portfolio with more than 1,800 products, and seven R&D centers.WHY: This strategic move strengthens Megalabs' position in both the global dermatology market and the USA. For Megalabs, dermatology is a key focus area with a long and successful track record driven by its Medihealth line, including a wide portfolio of products, and more recently entering the minimally invasive aesthetics and fillers market with the acquisition of Croma-Pharma in Brazil and the distribution of its products in the Latam region.DS Labs’ portfolio of products will significantly strengthen Megalabs’ position in dermatology, making its offering more competitive and comprehensive. This solidifies Megalabs as one of the market leaders in Mexico and Latam.